相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Synaptic Localization of GLT-1a in the Rat Somatic Sensory Cortex
Marcello Melone et al.
GLIA (2009)
GLT-1 Upregulation Impairs Prepulse Inhibition of the Startle Reflex in Adult Rats
Michele Bellesi et al.
GLIA (2009)
Up-regulation of GLT-1 severely impairs LTD at mossy fibre-CA3 synapses
Azar Omrani et al.
JOURNAL OF PHYSIOLOGY-LONDON (2009)
GLT-1 up-regulation enhances the effect of PCP on prepulse inhibition of the startle reflex in adult rats
Marcello Melone et al.
SCHIZOPHRENIA RESEARCH (2009)
Shared gene expression alterations in schizophrenia and bipolar disorder
Ling Shao et al.
BIOLOGICAL PSYCHIATRY (2008)
Receptor Actions of Synaptically Released Glutamate: The Role of Transporters on the Scale from Nanometers to Microns
Kaiyu Zheng et al.
BIOPHYSICAL JOURNAL (2008)
Metabotropic glutamate receptor agonists for schizophrenia
Paul J. Harrison
BRITISH JOURNAL OF PSYCHIATRY (2008)
GLT-1 expression and Glu uptake in rat cerebral cortex are increased by phencyclidine
Giorgia Fattorini et al.
GLIA (2008)
Mechanism of ceftriaxone induction of excitatory amino acid transporter-2 expression and glutamate uptake in primary human astrocytes
Seok-Geun Lee et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Transgenic mice lacking NMDAR-dependent LTD exhibit deficits in behavioral flexibility
Russell E. Nicholls et al.
NEURON (2008)
Transporters for L-glutamate: An update on their molecular pharmacology and pathological involvement
P. M. Beart et al.
BRITISH JOURNAL OF PHARMACOLOGY (2007)
Glutamate transporters: confining runaway excitation by shaping synaptic transmission
Anastassios V. Tzingounis et al.
NATURE REVIEWS NEUROSCIENCE (2007)
EAAT2 regulation and splicing: relevance to psychiatric and neurological disorders
T. L. Lauriat et al.
MOLECULAR PSYCHIATRY (2007)
The role of glutamate transporters in neurodegenerative diseases and potential opportunities for intervention
Amanda L. Sheldon et al.
NEUROCHEMISTRY INTERNATIONAL (2007)
Parallel loss of hippocampal LTD and cognitive flexibility in a genetic model of hyperdopaminergia
Elise Morice et al.
NEUROPSYCHOPHARMACOLOGY (2007)
Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: a randomized Phase 2 clinical trial
Sandeep T. Patil et al.
NATURE MEDICINE (2007)
Prepulse inhibition and P50 suppression are both deficient but not correlated in schizophrenia patients
David L. Braff et al.
BIOLOGICAL PSYCHIATRY (2007)
Selective dysfunction of hippocampal CA1 astrocytes contributes to delayed neuronal damage after transient forebrain ischemia
Yi-Bing Ouyang et al.
JOURNAL OF NEUROSCIENCE (2007)
The relationship between sensorimotor gating and clinical improvement in acutely ill schizophrenia patients
Arpi Minassian et al.
SCHIZOPHRENIA RESEARCH (2007)
Pharmacological induction of ischemic tolerance by glutamate transporter-1 (EAAT2) upregulation
Kon Chu et al.
STROKE (2007)
Startle gating deficits in a large cohort of patients with schizophrenia - Relationship to medications, symptoms, neurocognition, and level of function
Neal R. Swerdlow et al.
ARCHIVES OF GENERAL PSYCHIATRY (2006)
Metabotropic glutamate receptors
Francesco Ferraguti et al.
CELL AND TISSUE RESEARCH (2006)
GLT-1 down-regulation induced by clozapine in rat frontal cortex is associated with synaptophysin up-regulation
Luca Bragina et al.
JOURNAL OF NEUROCHEMISTRY (2006)
Cognitive dysfunction in schizophrenia -: Convergence of γ-aminobutyric acid and glutamate alterations
David A. Lewis et al.
ARCHIVES OF NEUROLOGY (2006)
Effects of the mGluR2/3 agonist LY379268 on ketamine-evoked behaviours and neurochemical changes in the dentate gyrus of the rat
Gabor Imre et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2006)
Pathophysiologically based treatment interventions in schizophrenia
David A. Lewis et al.
NATURE MEDICINE (2006)
Light microscopic identification and immunocytochemical characterization of glutamatergic synapses in brain sections
M Melone et al.
JOURNAL OF COMPARATIVE NEUROLOGY (2005)
Clozapine reduces GLT-1 expression and glutamate uptake in astrocyte cultures
A Vallejo-Illarramendi et al.
GLIA (2005)
Increased expression of the astrocytic glutamate transporter GLT-1 in the prefrontal cortex of schizophrenics
C Matute et al.
GLIA (2005)
Housekeeping proteins: A preliminary study illustrating some limitations as useful references in protein expression studies
RE Ferguson et al.
PROTEOMICS (2005)
β-Lactam antibiotics offer neuroprotection by increasing glutamate transporter expression
JD Rothstein et al.
NATURE (2005)
The glutamate transporter GLT1a is expressed in excitatory axon terminals of mature hippocampal neurons
WZ Chen et al.
JOURNAL OF NEUROSCIENCE (2004)
The selective serotonin-2A receptor antagonist M100907 reverses behavioral deficits in dopamine transporter knockout mice
AM Barr et al.
NEUROPSYCHOPHARMACOLOGY (2004)
Targeting metabotropic glutamate receptors for treatment of the cognitive symptoms of schizophrenia
B Moghaddam
PSYCHOPHARMACOLOGY (2004)
Association study of polymorphisms in the excitatory amino acid transporter 2 gene (SLC1A2) with schizophrenia
Xiangdong Deng et al.
BMC PSYCHIATRY (2004)
Daily variations in ceftriaxone pharmacokinetics in rats
M Rebuelto et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
Perisynaptic asymmetry of glia: new insights into glutamate signalling
DA Rusakov et al.
TRENDS IN NEUROSCIENCES (2002)
Effects of the mGlu2/3 receptor agonist LY379268 on motor activity in phencyclidine-sensitized rats
M Clark et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2002)
Mouse genetic models for prepulse inhibition: an early review
MA Geyer et al.
MOLECULAR PSYCHIATRY (2002)
Striatal excitatory amino acid transporter transcript expression in schizophrenia, bipolar disorder, and major depressive disorder
RE McCullumsmith et al.
NEUROPSYCHOPHARMACOLOGY (2002)
Expression of excitatory amino acid transporter transcripts in the thalamus of subjects with schizophrenia
RE Smith et al.
AMERICAN JOURNAL OF PSYCHIATRY (2001)
Human studies of prepulse inhibition of startle: normal subjects, patient groups, and pharmacological studies
DL Braff et al.
PSYCHOPHARMACOLOGY (2001)
Neural circuit regulation of prepulse inhibition of startle in the rat: current knowledge and future challenges
NR Swerdlow et al.
PSYCHOPHARMACOLOGY (2001)
The expression of glutamate transporter GLT-1 in the rat cerebral cortex is down-regulated by the antipsychotic drug clozapine
M Melone et al.
MOLECULAR PSYCHIATRY (2001)
Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review
MA Geyer et al.
PSYCHOPHARMACOLOGY (2001)
The glial glutamate transporter GLT-1 is localized both in the vicinity of and at distance from axon terminals in the rat cerebral cortex
A Minelli et al.
NEUROSCIENCE (2001)
On the clinical and cognitive meaning of impaired sensorimotor gating in schizophrenia
ME Dawson et al.
PSYCHIATRY RESEARCH (2000)
Animal models of deficient sensorimotor gating: what we know, what we think we know, and what we hope to know soon
NR Swerdlow et al.
BEHAVIOURAL PHARMACOLOGY (2000)
Schizophrenia: the fundamental questions
NC Andreasen
BRAIN RESEARCH REVIEWS (2000)
Attenuation of specific PCP-evoked behaviors by the potent mGlu2/3 receptor agonist, LY379268 and comparison with the atypical antipsychotic, clozapine
J Cartmell et al.
PSYCHOPHARMACOLOGY (2000)
Glutamate spillover suppresses inhibition by activating presynaptic mGluRs
SJ Mitchell et al.
NATURE (2000)
Schizophrenia and the mechanisms of conscious integration
G Tononi et al.
BRAIN RESEARCH REVIEWS (2000)
分享论文
